Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-lambda
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG4-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG2-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
NN9828
Feline
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG4
REGN1909
Zaire ebolavirus (ZEBOV) (Zaire Ebola virus), Bundibugyo virus (BDBV), Sudan ebolavirus (SEBOV) (Sudan Ebola virus), Tai Forest ebolavirus (TAFV) (Cote d'Ivoire Ebola virus), Reston ebolavirus (REBOV) (Reston Ebola virus)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
ADI-15878